Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small molecules keep mitotic kinases in check.

Klaus Strebhardt1

  • 1Department of Obstetrics and Gynecology, School of Medicine, J. W. Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. strebhardt@em.uni-frankfurt.de

ACS Chemical Biology
|December 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.

Cancers·2025
Same author

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.

Cancer communications (London, England)·2025
Same author

Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.

Cancer gene therapy·2025
Same author

Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors.

Cancers·2024
Same author

Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.

Cancer communications (London, England)·2023
Same author

Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1.

Oncogene·2023

New methods like homology modeling and phenotype screening advance small molecule discovery for protein kinases. Targeting polo-like kinases offers insights into cell division control.

Area of Science:

  • Biochemistry and Molecular Biology
  • Drug Discovery
  • Cell Biology

Background:

  • Protein kinases are crucial drug targets, with ongoing advancements in small molecule discovery.
  • Understanding kinase function is key to developing targeted therapies for various diseases.

Purpose of the Study:

  • To highlight novel approaches in small molecule kinase inhibitor discovery.
  • To explore the role of polo-like kinase inhibitors in understanding cell division.

Main Methods:

  • Utilizing homology modeling for rational drug design.
  • Employing phenotype-based screening for identifying bioactive compounds.
  • Investigating compounds targeting the nucleotide binding pockets of polo-like kinases.

Main Results:

Related Experiment Videos

  • Successful application of homology modeling and phenotype-based screening for kinase inhibitor discovery.
  • Identification of compounds targeting polo-like kinases.
  • New insights into molecular mechanisms regulating cell division phenotypes.

Conclusions:

  • Homology modeling and phenotype-based screening represent powerful alternative strategies for kinase inhibitor development.
  • Targeting polo-like kinases provides valuable understanding of cell cycle regulation.
  • These approaches contribute significantly to the field of targeted therapeutics.